(21 days)
Not Found
No
The device description and performance studies focus on the mechanical and physical properties of a steerable introducer, with no mention of AI or ML technologies.
No
The device is an introducer for catheters, not a therapeutic device itself. Its purpose is to facilitate the introduction of other devices that may be therapeutic.
No
The device is described as an "introducer" for various cardiovascular catheters, designed to facilitate their positioning and introduction into the heart. Its features like a hemostasis valve and sideport are for minimizing blood loss, aspiration, infusion, and monitoring, not for diagnosing conditions.
No
The device description clearly outlines physical components such as a dilator, guidewire, steerable sheath, hemostasis valve, sideport, handle, and radiopaque tip marker, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to introduce cardiovascular catheters into the heart. This is a procedure performed on the patient, not a test performed on a sample taken from the patient.
- Device Description: The device is a physical tool (introducer, dilator, guidewire) used to facilitate a medical procedure. It does not involve analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing blood, tissue, or other biological samples, which is the core function of an IVD.
This device is a medical device used for a procedural purpose, not for diagnostic testing of biological samples.
N/A
Intended Use / Indications for Use
The Agilis™ NxT Steerable Introducer is indicated when introducing various cardiovascular catheters into the heart.
Product codes (comma separated list FDA assigned to the subject device)
DYB
Device Description
The St. Jude Medical Agilis™ NxT Stecrable Introducer set consists of a dilator, guidewire, and steerable sheath, which is designed to provide flexible catheter positioning in the cardiac anatomy. The steerable introducer if fitted with a hemostasis valve to minimize blood loss during catheter introduction and/or exchange. A sideport with three-way stopcock is provided for air or blood aspiration, fluid infusion, blood sampling and pressure monitoring. A handle equipped with a rotating collar to deflect the tip clockwise ≥ 180° and counter-clockwise ≥ 90°15 The steerable introducer features distal vent holes to facilitate aspiration and minimize cavitation and a radiopaque tip marker to improve fluoroscopic visualization.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
heart
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench testing of the Agilis™ NxT Stecrable Introducer was performed to support substantial equivalence. Results of the testing demonstrate that the Agilis™ NxT Steerable Introducer meets product specifications and performance requirements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1340 Catheter introducer.
(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).
0
510(k) Summary As required by 21 CFR 807.92(c)
s required by 21 CFR 807.92(c)
NOV - 6 2008
510(k) Number:
Date Prepared:
October 3, 2008
Submitter Information:
Submitter's Name/ Address:
St. Jude Medical 14901 DeVeau Place Minnetonka, MN 55345-2126
Contact Person:
Laura Moen-Ftacek Regulatory Affairs Specialist Tel: 952-351-1453 Fax: 952-930-9481 Imoen-ftacek@sjm.com
Device Information:
Trade Name: Common Name: Classification Name: Class:
Agilis™ NxT Steerable Introducer Catheter Introducer Introducer, Catheter Class II, 21 CFR 870.1340, Product Code DYB
Predicate Device:
St. Jude Medical Agilis™ NxT Steerable Introducer, Catheter Introducer (K061363)
Device Description:
The St. Jude Medical Agilis™ NxT Stecrable Introducer set consists of a dilator, guidewire, and steerable sheath, which is designed to provide flexible catheter positioning in the cardiac anatomy. The steerable introducer if fitted with a hemostasis valve to minimize blood loss during catheter introduction and/or exchange. A sideport with three-way stopcock is provided for air or blood aspiration, fluid infusion, blood sampling and pressure monitoring. A handle equipped with a rotating collar to deflect the tip clockwise ≥ 180° and counter-clockwise ≥ 90°15 The steerable introducer features distal vent holes to facilitate aspiration and minimize cavitation and a radiopaque tip marker to improve fluoroscopic visualization.
Indications for Use:
The Agilis™ NxT Steerable Introducer is indicated when introducing various cardiovascular catheters into the heart.
1
Comparison to Predicate Devices:
The Agilis™ NxT Steerable Introducer (40cm) has an Indication for Use statement that is included in the broader Indications for Use statement of the predicate Agilis™ NxT Steerable Introducer. The Agilis™ NxT Steerable Introducer (40cm) utilizes many of the same materials and design principles and the fumdamental scientific technology of the device remain unchanged,
Summary of Non-Clinical Testing:
Bench testing of the Agilis™ NxT Stecrable Introducer was performed to support substantial equivalence. Results of the testing demonstrate that the Agilis™ NxT Steerable Introducer meets product specifications and performance requirements.
Statement of Equivalence:
The Agilis™ NxT Steerable Introducer has similar indications for use and technological characteristics as the predicate device. Based on this and the design and engineering data provided in the pre-market notification, SJM's Agilis™ NxT Steerable Introducer has been shown to be substantially equivalent.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three tail feathers. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV - 6 2008
St. Jude Medical c/o Mr. Mark Job Regulatory Technology Services, LLC 1394 25th Street, NW Buffalo, MN 55313
Re: K083083
Agilis NXT Steerable Introducer Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter introducer Regulatory Class: Class II (two) Product Code: DYB Dated: October 15, 2008 Received: October 16, 2008
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. T o general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA moy publish further announcements concerning your device in the Federal Register.
3
Page 2 Mr. Mark Job
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FIDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Dma R. Vochner
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE
510(K) Number (if known):
Device Name: AgilisTM NxT Steerable Introducer
Indications for Use:
The Agilis™ NxT Steerable Introducer is indicated when introducing various cardiovascular catheters into the heart.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
oning & la misses
Page 1 of 1
Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number_KO8308 3